Ocean Nutrition Canada last week announced a new partnership with Wilmar International to develop omega-3 cooking oil for the China market.
Ocean Nutrition Canada last week announced a new partnership with Wilmar International to develop omega-3 cooking oil for the China market.
The companies will incorporate Ocean Nutrition’s Meg-3 omega-3 into Wilmar’s Arawana 3+ blended cooking oil. Singapore-based Wilmar is the biggest seller of cooking oil in China and represents 48% of the market, said Ocean Nutrition.
The deal is significant, as cooking oil is a leading SKU in China, used as a standard ingredient for cooking in woks.
The companies say research by Wilmar confirmed that the average Chinese consumer takes in only 37.6 mg of EPA and DHA daily, which is less than 25% of the EPA/DHA level accepted by the United States’ Institute of Medicine and less than 10% of the intake recommended by the International Society for the Study of Fatty Acids and Lipids.
Robert Orr, Ocean Nutrition’s chairman, called the deal a “significant breakthrough” for the Chinese market.
“Today, most of the products that have omega-3 EPA and DHA in them have been lifestyle products,” he said. “[Wilmar] felt that cooking oil is so widely used in China, and they are so committed to health and wellness that this would really up their intake of omega-3s, particularly EPA and DHA.”
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.